HOLLY HARRIS to Ovarian Neoplasms
This is a "connection" page, showing publications HOLLY HARRIS has written about Ovarian Neoplasms.
Connection Strength
4.993
-
Infertility and Risk of Ovarian Cancer in the Women's Health Initiative. Cancer Causes Control. 2025 Jun; 36(6):617-624.
Score: 0.674
-
Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer Risk. J Clin Oncol. 2024 Aug 01; 42(22):2619-2621.
Score: 0.641
-
Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium. Int J Cancer. 2022 10 15; 151(8):1228-1239.
Score: 0.563
-
Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium. Cancer Epidemiol Biomarkers Prev. 2021 09; 30(9):1660-1668.
Score: 0.525
-
Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression. Cancer Epidemiol Biomarkers Prev. 2018 01; 27(1):96-102.
Score: 0.409
-
Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2017 Jan 15; 140(2):285-291.
Score: 0.379
-
Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium. Cancer Epidemiol Biomarkers Prev. 2025 Dec 01; 34(12):2302-2305.
Score: 0.178
-
Associations between Parity, History of Breastfeeding, and T-cell Profile of Ovarian Tumors. Cancer Epidemiol Biomarkers Prev. 2025 Apr 03; 34(4):550-559.
Score: 0.170
-
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium. Am J Epidemiol. 2024 Sep 03; 193(9):1242-1252.
Score: 0.164
-
Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2023 08 01; 32(8):1087-1096.
Score: 0.152
-
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. JAMA Netw Open. 2023 02 01; 6(2):e230666.
Score: 0.147
-
Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1610-1620.
Score: 0.142
-
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins. Cancer Epidemiol Biomarkers Prev. 2021 05; 30(5):927-935.
Score: 0.128
-
Sleep Characteristics and Risk of Ovarian Cancer Among Postmenopausal Women. Cancer Prev Res (Phila). 2021 01; 14(1):55-64.
Score: 0.124
-
Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. JAMA. 2020 01 07; 323(1):49-59.
Score: 0.119
-
Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Int J Cancer. 2019 10 15; 145(8):2051-2060.
Score: 0.111
-
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. J Natl Cancer Inst. 2019 01 01; 111(1):60-68.
Score: 0.111
-
Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1509-1517.
Score: 0.109
-
Histotype classification of ovarian carcinoma: A comparison of approaches. Gynecol Oncol. 2018 10; 151(1):53-60.
Score: 0.108
-
Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials. J Clin Oncol. 2024 Oct 20; 42(30):3537-3549.
Score: 0.041